Analysts at Canaccord Genuity Group assumed coverage on shares of Wise (LON:WISE – Get Free Report) in a research report issued on Wednesday, Digital Look reports. The brokerage set a “buy” rating and a GBX 1,171 price target on the stock. Canaccord Genuity Group’s target price points to a potential upside of 21.35% from the company’s current price.
Other analysts have also recently issued reports about the company. JPMorgan Chase & Co. lowered their price target on Wise from GBX 1,320 to GBX 1,300 and set an “overweight” rating on the stock in a research report on Friday, July 17th. Jefferies Financial Group cut their price objective on Wise from GBX 1,299 to GBX 1,239 and set a “buy” rating for the company in a report on Thursday, July 9th. Berenberg Bank restated a “buy” rating on shares of Wise in a research note on Thursday, June 11th. Finally, Peel Hunt reaffirmed a “hold” rating and issued a GBX 900 target price on shares of Wise in a report on Friday, July 24th. Four equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of GBX 1,192.
Read Our Latest Analysis on WISE
Wise Stock Up 0.5%
Wise Company Profile
Wise plc provides cross-border and domestic financial services for personal and business customers in the United Kingdom, rest of Europe, the Asia-Pacific, North America, and internationally. Its product portfolio includes international money transfer, wise account, international debit card, amount transfer, receive money, wise platform, business debit card, and mass payment services. The company was formerly known as 456 Newco plc and changed its name to Wise plc in June 2021. Wise plc was founded in 2010 and is based in London, the United Kingdom.
Further Reading
- Five stocks we like better than Wise
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Receive News & Ratings for Wise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wise and related companies with MarketBeat.com's FREE daily email newsletter.
